 | Aridis Pharmaceuticals Inc (NASDAQ:ARDS) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 16 at 2:16 AM |
| Aridis Pharmaceuticals' (ARDS) Buy Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - May 15 at 5:49 PM |
| Aridis Pharmaceuticals (NASDAQ:ARDS) Releases Earnings Results, Misses Expectations By $0.06 EPS
www.americanbankingnews.com - May 13 at 6:16 PM |
 | Aridis Pharmaceuticals EPS misses by $0.19
seekingalpha.com - May 12 at 5:20 PM |
 | Aridis Pharmaceuticals Announces First Quarter 2020 Results
finance.yahoo.com - May 12 at 5:20 PM |
| Reviewing Eyegate Pharmaceuticals (NASDAQ:EYEG) and Aridis Pharmaceuticals (NASDAQ:ARDS)
www.americanbankingnews.com - May 11 at 12:42 PM |
| Aridis Pharmaceuticals (NASDAQ:ARDS) Now Covered by Analysts at Maxim Group
www.americanbankingnews.com - May 7 at 12:04 AM |
 | BRIEF-Aridis Pharmaceuticals Enrolls First Covid-19 Patient In Ongoing Phase 3 AR-301 Clinical Trial
www.reuters.com - May 5 at 6:23 PM |
| Aridis Pharm enrolls first COVID-19 patient in late-stage AR-301 trial
seekingalpha.com - May 4 at 7:58 AM |
| Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)
finance.yahoo.com - May 4 at 7:58 AM |
|
| Aridis Pharmaceuticals to Participate in Maxim Group's Infectious Disease Virtual Conference
finance.yahoo.com - April 29 at 8:00 AM |
| Can Aridis Pharmaceuticals’ APEX Platform Be Used to Target Coronavirus? Analyst Weighs In
finance.yahoo.com - April 15 at 5:28 PM |
| Aridis Pharmaceuticals EPS beats by $0.17
seekingalpha.com - April 8 at 7:33 PM |
| Aridis Pharmaceuticals to Postpone Investor Day Due to Coronavirus Concerns
finance.yahoo.com - March 6 at 5:59 PM |
| Aridis Pharmaceuticals to Present at the 32nd Annual ROTH Conference
finance.yahoo.com - March 5 at 11:37 AM |
| Aridis Pharmaceuticals Provides Update on Investor Day Featuring Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
finance.yahoo.com - March 4 at 7:49 AM |
| San Jose biotech incubator where Impossible Foods hatched expands at new site
finance.yahoo.com - February 28 at 2:58 PM |
| Aridis Pharmaceuticals to Host Investor Day Showcasing APEX™ Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
finance.yahoo.com - February 18 at 7:56 AM |
 | Aridis Pharmaceuticals Inc. Common Stock (ARDS) Dividend History
www.nasdaq.com - February 12 at 6:23 PM |
| Aridis Pharmaceuticals Inc. Common Stock (ARDS) Revenue EPS
www.nasdaq.com - February 12 at 6:23 PM |
| We're Hopeful That Aridis Pharmaceuticals (NASDAQ:ARDS) Will Use Its Cash Wisely
finance.yahoo.com - January 17 at 8:31 AM |
| We're Hopeful That Aridis Pharmaceuticals (NASDAQ:ARDS) Will Use Its Cash Wisely
finance.yahoo.com - January 17 at 8:31 AM |
| Aridis Pharma Up Over 30% In 3 Trading Days, Awaits Phase 3 Data In Early 2020
www.nasdaq.com - January 7 at 1:32 AM |
| New finance chief at Aridis Pharma
seekingalpha.com - January 2 at 4:09 PM |
| Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
finance.yahoo.com - January 2 at 6:45 AM |
| Aridis Pharma up 43% on development of new antibody platform
seekingalpha.com - December 30 at 8:18 PM |
| Aridis Pharmaceuticals Inc. Common Stock (ARDS) Earnings Report Date
www.nasdaq.com - November 13 at 5:55 PM |
| Aridis Pharmaceuticals Announces Third Quarter 2019 Results
finance.yahoo.com - November 13 at 5:55 PM |
| Introducing Aridis Pharmaceuticals (NASDAQ:ARDS), The Stock That Slid 52% In The Last Year
finance.yahoo.com - October 19 at 12:53 PM |
| Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
finance.yahoo.com - October 19 at 7:53 AM |
| Aridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology
finance.yahoo.com - September 30 at 8:19 AM |
| Aridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 27 at 7:20 AM |
| Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium Citrate) Data at IDWeek™ 2019
finance.yahoo.com - September 27 at 7:20 AM |
| Aridis Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019
finance.yahoo.com - September 20 at 3:25 AM |
 | Aridis Pharmaceuticals Reports Phase 2 Clinical...
www.benzinga.com - September 3 at 12:51 PM |
| Aridis Pharma's AR-105 flunks mid-stage study; shares down 27% premarket
seekingalpha.com - September 3 at 12:51 PM |
| Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa
finance.yahoo.com - September 3 at 12:51 PM |
| Aridis Pharmaceuticals stock plunges after drug trial fails to meet primary endpoint
finance.yahoo.com - September 3 at 12:51 PM |
| Aridis Pharmaceuticals Announces Second Quarter 2019 Results
finance.yahoo.com - August 12 at 10:23 PM |
| Aridis Pharma inks option deal with Indian vaccine maker for pipeline programs and MabIgX platform
seekingalpha.com - August 1 at 3:55 PM |
| Do Insiders Own Lots Of Shares In Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS)?
finance.yahoo.com - July 31 at 6:24 PM |
| Aridis Pharma inks option deal with Indian vaccine maker for MabIgX platform
seekingalpha.com - July 30 at 11:54 AM |
| Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform Technology
finance.yahoo.com - July 30 at 11:54 AM |
| Aridis Pharma's AR-501 an Orphan drug in Europe
seekingalpha.com - July 19 at 1:33 PM |
| Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501
finance.yahoo.com - July 5 at 11:24 AM |
| Aridis Pharma's AR-501 an Orphan Drug in U.S. for CF lung infection
seekingalpha.com - June 27 at 11:33 AM |
| Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
finance.yahoo.com - June 10 at 12:23 PM |
| Aridis Pharmaceuticals Announces First Quarter 2019 Results
finance.yahoo.com - May 15 at 11:32 AM |
| Will Aridis Pharmaceuticals Continue to Surge Higher?
www.nasdaq.com - April 3 at 9:08 AM |
| Aridis Pharmaceuticals (ARDS) Upgraded to Buy: Here's Why
www.nasdaq.com - April 2 at 9:12 PM |
